LetterNon-neutralizing antibodies and limitations of serologic testing for severe acute respiratory syndrome coronavirus 2 in patients receiving immunoglobulin replacement products
Cited by (0)
Disclosures: The authors have no conflicts of interest to report.
Funding: The authors have no funding sources to report.
© 2020 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.